{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T18:50:41Z","timestamp":1693421441730},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.transproceed.2017.01.024","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T09:58:34Z","timestamp":1490176714000},"page":"575-579","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Dosage and Type of Hepatitis B Immunoglobulin on Hepatitis Antibody Levels in Liver Transplant Recipients"],"prefix":"10.1016","volume":"49","author":[{"given":"A.","family":"Ulku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Akcam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rencuzogullari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dalci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Yalav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.C.","family":"Eray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Saritas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.01.024_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.transproceed.2011.01.006","article-title":"Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation","volume":"43","author":"Sevmis","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.024_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.transproceed.2015.04.018","article-title":"Antiviral combination therapy with low-dose hepatitis B immunoglobulin for the prevention of hepatitis B virus recurrence in liver transplant recipients: a single-center experience","volume":"47","author":"Akcam","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.024_bib3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ctr.12804","article-title":"The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence","volume":"30","author":"Idilman","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2017.01.024_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0168-8278(91)90869-D","article-title":"Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization","volume":"13","author":"M\u00fcller","year":"1991","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2017.01.024_bib5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"Grellier","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2017.01.024_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.510240601","article-title":"Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin","volume":"24","author":"Terrault","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.01.024_bib7","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/j.transproceed.2010.07.011","article-title":"Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation","volume":"42","author":"Pauwelyn","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.024_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.dld.2009.09.005","article-title":"Efficacy, safety, and pharmacokinetics of intramuscular hepatitis B immune globulin, Igantibe, for the prophylaxis of viral B hepatitis after liver transplantation","volume":"42","author":"Filipponi","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.transproceed.2017.01.024_bib9","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.transproceed.2011.02.013","article-title":"Safety of ultra-rapid intravenous infusion of hepatitis B immunoglobulin in liver transplant recipients","volume":"43","author":"Hwang","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.024_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1600-6143.2010.03046.x","article-title":"Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation","volume":"10","author":"Degertekin","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.01.024_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/eci.11.30","article-title":"Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation","volume":"7","author":"Congly","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.transproceed.2017.01.024_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-0012.2007.00678.x","article-title":"Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens","volume":"21","author":"Anderson","year":"2007","journal-title":"Clin Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2017.01.024_bib13","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/lt.21614","article-title":"Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin\/antiviral regimen?","volume":"14","author":"Angus","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.01.024_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/lt.21343","article-title":"Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation","volume":"14","author":"Hooman","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.01.024_bib15","first-page":"373","article-title":"Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation","volume":"101","author":"Marzano","year":"2010","journal-title":"Minerva Med"},{"key":"10.1016\/j.transproceed.2017.01.024_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-2277.2011.01222.x","article-title":"Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra) in liver transplantation: an open, prospective, single-arm phase III study","volume":"24","author":"Yahyazadeh","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2017.01.024_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-6143.2012.04319.x","article-title":"Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study","volume":"13","author":"Di Costanzo","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.01.024_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s12072-011-9265-z","article-title":"Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis","volume":"5","author":"Yasunaka","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.transproceed.2017.01.024_bib19","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1111\/tri.12368","article-title":"Tenofovir disoproxil fumarate rescue therapy for HBV recurrence in two transplant recipients with previous multiple nucleo(s\/t) ide treatment failures","volume":"27","author":"Rao","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2017.01.024_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/lt.20701","article-title":"Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis","volume":"12","author":"Zheng","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.01.024_bib21","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3346\/jkms.2016.31.12.1937","article-title":"Antibodies against hepatitis A and hepatitis B virus in intravenous immunoglobulin products","volume":"31","author":"Lee","year":"2016","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.transproceed.2017.01.024_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12664-014-0457-z","article-title":"Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients","volume":"33","author":"Varghese","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.transproceed.2017.01.024_bib23","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.transproceed.2010.05.127","article-title":"Efficacy and safety of entecavir and\/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant","volume":"42","author":"Jim\u00e9nez-P\u00e9rez","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.024_bib24","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.gastro.2011.06.083","article-title":"Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation","volume":"141","author":"Fung","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2017.01.024_bib25","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.transproceed.2013.08.065","article-title":"Clinical outcomes and risk factors of hepatitis B virus recurrence in patients who received prophylaxis with entecavir and hepatitis B immunoglobulin following liver transplantation","volume":"45","author":"Kim","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.024_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/lt.23690","article-title":"Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B","volume":"19","author":"Perrillo","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.01.024_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/tid.12575","article-title":"Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation","volume":"18","author":"Cholongitas","year":"2016","journal-title":"Transpl Infect Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517300349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517300349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T05:21:27Z","timestamp":1535952087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517300349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0041134517300349"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.024","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Dosage and Type of Hepatitis B Immunoglobulin on Hepatitis Antibody Levels in Liver Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}